rs4919686

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000102.4(CYP17A1):​c.1139+19T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.255 in 1,550,476 control chromosomes in the GnomAD database, including 55,070 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 4200 hom., cov: 31)
Exomes 𝑓: 0.26 ( 50870 hom. )

Consequence

CYP17A1
NM_000102.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.55
Variant links:
Genes affected
CYP17A1 (HGNC:2593): (cytochrome P450 family 17 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. It has both 17alpha-hydroxylase and 17,20-lyase activities and is a key enzyme in the steroidogenic pathway that produces progestins, mineralocorticoids, glucocorticoids, androgens, and estrogens. Mutations in this gene are associated with isolated steroid-17 alpha-hydroxylase deficiency, 17-alpha-hydroxylase/17,20-lyase deficiency, pseudohermaphroditism, and adrenal hyperplasia. [provided by RefSeq, Jul 2008]
WBP1L (HGNC:23510): (WW domain binding protein 1 like) Predicted to enable ubiquitin protein ligase binding activity. Predicted to act upstream of or within CXCL12-activated CXCR4 signaling pathway; hemopoiesis; and positive regulation of protein ubiquitination. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 10-102832492-A-C is Benign according to our data. Variant chr10-102832492-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 137063.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-102832492-A-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.295 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CYP17A1NM_000102.4 linkuse as main transcriptc.1139+19T>G intron_variant ENST00000369887.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CYP17A1ENST00000369887.4 linkuse as main transcriptc.1139+19T>G intron_variant 1 NM_000102.4 P3

Frequencies

GnomAD3 genomes
AF:
0.212
AC:
32236
AN:
151868
Hom.:
4200
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0703
Gnomad AMI
AF:
0.182
Gnomad AMR
AF:
0.212
Gnomad ASJ
AF:
0.301
Gnomad EAS
AF:
0.144
Gnomad SAS
AF:
0.0972
Gnomad FIN
AF:
0.269
Gnomad MID
AF:
0.266
Gnomad NFE
AF:
0.299
Gnomad OTH
AF:
0.225
GnomAD3 exomes
AF:
0.226
AC:
56453
AN:
250178
Hom.:
7340
AF XY:
0.227
AC XY:
30720
AN XY:
135366
show subpopulations
Gnomad AFR exome
AF:
0.0649
Gnomad AMR exome
AF:
0.178
Gnomad ASJ exome
AF:
0.288
Gnomad EAS exome
AF:
0.148
Gnomad SAS exome
AF:
0.102
Gnomad FIN exome
AF:
0.272
Gnomad NFE exome
AF:
0.294
Gnomad OTH exome
AF:
0.253
GnomAD4 exome
AF:
0.260
AC:
362997
AN:
1398490
Hom.:
50870
Cov.:
25
AF XY:
0.257
AC XY:
179419
AN XY:
699356
show subpopulations
Gnomad4 AFR exome
AF:
0.0615
Gnomad4 AMR exome
AF:
0.182
Gnomad4 ASJ exome
AF:
0.285
Gnomad4 EAS exome
AF:
0.101
Gnomad4 SAS exome
AF:
0.104
Gnomad4 FIN exome
AF:
0.274
Gnomad4 NFE exome
AF:
0.287
Gnomad4 OTH exome
AF:
0.248
GnomAD4 genome
AF:
0.212
AC:
32231
AN:
151986
Hom.:
4200
Cov.:
31
AF XY:
0.208
AC XY:
15461
AN XY:
74300
show subpopulations
Gnomad4 AFR
AF:
0.0701
Gnomad4 AMR
AF:
0.211
Gnomad4 ASJ
AF:
0.301
Gnomad4 EAS
AF:
0.144
Gnomad4 SAS
AF:
0.0983
Gnomad4 FIN
AF:
0.269
Gnomad4 NFE
AF:
0.299
Gnomad4 OTH
AF:
0.223
Alfa
AF:
0.274
Hom.:
9043
Bravo
AF:
0.203
Asia WGS
AF:
0.103
AC:
359
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsNov 02, 2017- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxFeb 10, 2014This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Deficiency of steroid 17-alpha-monooxygenase Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 01, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.032
DANN
Benign
0.39

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4919686; hg19: chr10-104592249; COSMIC: COSV64004884; COSMIC: COSV64004884; API